Prograf and Lanthanum carbonate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Prograf and Lanthanum carbonate. Common interactions include deep vein thrombosis among females and cholecystitis among males.

The phase IV clinical study analyzes what interactions people who take Prograf and Lanthanum carbonate have. It is created by eHealthMe based on reports of 12 people who take Prograf and Lanthanum carbonate from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Mar, 26, 2023

12 people who take Prograf and Lanthanum carbonate together, and have interactions are studied.


What is Prograf?

Prograf has active ingredients of tacrolimus. It is often used in kidney transplant. eHealthMe is studying from 40,362 Prograf users for its effectiveness, alternative drugs and more.

What is Lanthanum carbonate?

Lanthanum carbonate has active ingredients of lanthanum carbonate. eHealthMe is studying from 1,290 Lanthanum carbonate users for its effectiveness, alternative drugs and more.

Number of Prograf and Lanthanum carbonate reports submitted per year:

Prograf and Lanthanum carbonate drug interactions.

Common Prograf and Lanthanum Carbonate drug interactions by gender *:

female:

  1. Deep vein thrombosis
  2. Haemolysis
  3. Herpes zoster
  4. Pyrexia
  5. Red blood cell count decreased

male:

  1. Cholecystitis
  2. Pericardial effusion
  3. Blood thyroid stimulating hormone increased
  4. Clostridium difficile colitis
  5. Decreased appetite
  6. Drug level increased
  7. Graft dysfunction
  8. Hyperkalaemia
  9. Nausea
  10. Serum ferritin increased

Common Prograf and Lanthanum Carbonate drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Deep vein thrombosis
  2. Haemolysis
  3. Pyrexia
  4. Red blood cell count decreased

40-49:

  1. Cholecystitis
  2. Pericardial effusion
  3. Pericarditis constrictive
  4. Blood pressure decreased

50-59:

  1. Gout
  2. Herpes zoster
  3. Hypercalcaemia
  4. Hypophosphataemia
  5. Pyrexia

60+:

  1. Encephalopathy
  2. Failure to thrive
  3. Graft dysfunction
  4. Hyperkalaemia
  5. Nausea
  6. Renal impairment
  7. Serum ferritin increased
  8. Vomiting
  9. Agitation
  10. Anaemia vitamin b12 deficiency

Common conditions people have *:

  1. High Blood Pressure: 2 people, 16.67%
  2. Stable Angina (a constant chest pain): 1 person, 8.33%
  3. Renal Disorder (kidney disease): 1 person, 8.33%
  4. Immunodeficiency Disorders: 1 person, 8.33%
  5. Hepatitis C: 1 person, 8.33%
  6. Haemolytic Uraemic Syndrome (blood clotting disease caused by e. coli infection, birth control pills, pneumonia, medications, and more): 1 person, 8.33%
  7. Fever: 1 person, 8.33%
  8. Chronic Kidney Disease: 1 person, 8.33%
  9. Arrhythmias (irregular heartbeat): 1 person, 8.33%
  10. Anaemia (lack of blood): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Prograf and Lanthanum carbonate?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Prograf and Lanthanum carbonate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Prograf side effects:

Browse all side effects of Prograf:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Lanthanum carbonate side effects:

Browse all side effects of Lanthanum carbonate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Prograf interactions:

Browse all interactions between Prograf and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Lanthanum carbonate interactions:

Browse all interactions between Lanthanum carbonate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on tacrolimus and lanthanum carbonate (the active ingredients of Prograf and Lanthanum carbonate, respectively), and Prograf and Lanthanum carbonate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Prograf and Lanthanum carbonate.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: